Dolby Laboratories
Organization details
- Legal name
- Dolby Laboratories
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Financials
- SIC code
- 6794 — Patent Owners & Lessors
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- September
- Ticker symbol
- DLB
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001308547
- EIN
- 90-0199783
- Wikidata ID
- Q261288
Board of directors
-
Anjali Sud · DirectorSince 2023
-
Avadis Tevanian · DirectorSince 2023
-
David Dolby · DirectorSince 2023
-
Emily Rollins · DirectorSince 2023
-
Kevin J. Yeaman · Director · President and CEOSince 2023
-
Marc Whitten · Director · President and CEOSince 2026
-
Micheline Chau · DirectorSince 2023
-
Peter C. Gotcher · DirectorSince 2023
-
Simon Segars · DirectorSince 2023
-
Tony A. Prophet · DirectorSince 2023
Chief executives
Director election results
Annual meeting of February 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.8%
-
96.4%
-
96.5%
-
96.5%
-
99.7%
-
99.8%
-
99.8%
-
99.8%
Board connections
4 of this board's directors also sit on 4 other boards.
- via Peter C. Gotcher
- via Micheline Chau
- via Anjali Sud
- via Emily Rollins
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $14,666,005
- 38 sales by 9 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Couling John D Officer (SVP, Entertainment) | Option exercise | +7,667 | $45.50 | $348,849 |
| Oct 1, 2026 | Couling John D Officer (SVP, Entertainment) | Open-market sale | −6,831 | $58.72 | $401,092 |
| Oct 1, 2026 | Couling John D Officer (SVP, Entertainment) | Open-market sale | −836 | $59.33 | $49,598 |
| Sep 15, 2026 | Couling John D Officer (SVP, Entertainment) | Grant or award | +48,076 | — | — |
| Sep 15, 2026 | SHERMAN MARK ANDREW Officer (EVP, Gen. Counsel & Secretary) | Grant or award | +48,076 | — | — |
| Sep 15, 2026 | Marc Whitten Director, Officer (President and CEO) | Grant or award | +160,256 | — | — |
| Sep 1, 2026 | Couling John D Officer (SVP, Entertainment) | Option exercise | +7,667 | $45.50 | $348,849 |
| Sep 1, 2026 | Couling John D Officer (SVP, Entertainment) | Open-market sale | −7,667 | $61.05 | $468,070 |
| Aug 28, 2026 | DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 10% owner | Derivative conversion | +300,000 | — | — |
| Aug 28, 2026 | DAGMAR DOLBY TRUST UNDER DOLBY FAMILY TRUST INSTRUMENT DATED MAY 7, 1999 10% owner | Gift | −300,000 | — | — |
| Aug 25, 2026 | Nicholson Ryan Officer (VP, CAO and Corp. Controller) | Open-market sale | −1,183 | $65.28 | $77,226 |
| Aug 14, 2026 | Revankar Shriram Officer (SVP, Advanced Technology Group) | Open-market sale | −3,000 | $62.71 | $188,130 |
| Aug 10, 2026 | Nicholson Ryan Officer (VP, CAO and Corp. Controller) | Open-market sale | −1,348 | $62.04 | $83,630 |
| Aug 4, 2026 | Nicholson Ryan Officer (VP, CAO and Corp. Controller) | Open-market sale | −357 | $60.63 | $21,645 |
| Aug 3, 2026 | Couling John D Officer (SVP, Entertainment) | Option exercise | +7,667 | $45.50 | $348,849 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Dolby Laboratories
Who is the CEO of Dolby Laboratories?
Marc Whitten has been Dolby Laboratories's President and CEO since August 2026.
How many directors are on Dolby Laboratories's board?
Dolby Laboratories's board has 10 directors: Anjali Sud, Avadis Tevanian, David Dolby, Emily Rollins, Kevin J. Yeaman, Marc Whitten, Micheline Chau, Peter C. Gotcher, Simon Segars and Tony A. Prophet.
Are Dolby Laboratories insiders buying or selling shares?
Over the last 12 months, Dolby Laboratories insiders made no open-market purchases and sold $14.7 million of shares in 38 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="dolby-laboratories"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.